Pause. Check the claim and the product.
Give an unclear answer time to be resolved before moving on.
Claims to look at closely
The Food and Drug Administration (FDA) pharmacy checklist treats an offer without a valid prescription as a warning sign. The FDA is the U.S. agency that checks medicines.
Under federal law checked September 26, 2026, prescription medicine may be dispensed only with a valid prescription.
The FDA’s consumer alert was checked September 26, 2026. It warns against weight medicines marked “for research purposes” or carrying a “not for human consumption” label. The quality is unknown; harm could result from using these products.
Those words on an offer do not show that it is part of a medical study.
Records checked September 26, 2026, show no FDA-approved generic tirzepatide. A generic medicine is approved as a version of a brand-name drug.
FDA registration means an entry in the agency’s records. A listing does not give a pharmacy or its products FDA approval, as checked September 26, 2026.
Compounding prepares or changes medicine for the needs of a particular patient.
The FDA also reports false pharmacy names on some compounded tirzepatide labels, in its alert checked September 26, 2026.
Ask who prescribed the medicine, who made it and which pharmacy supplied it. Then check the names in the state records.
The boxed warning needs a real conversation
The thyroid is a small organ at the front of the neck.
A boxed warning is the strongest warning on a medicine label. Both tirzepatide labels use it for thyroid tumors, or abnormal growths, seen in rats.
It is unknown if tirzepatide causes these tumors in people.
The labels rule out tirzepatide when medullary thyroid cancer has affected you or someone in your family. This is a rare cancer in that neck organ.
They also rule it out for MEN 2, a rare condition inherited through families, or a known serious allergy to any ingredient, including tirzepatide.
The pancreas is an organ behind the stomach. The gallbladder is a small organ under the liver that stores fluid used to digest food.
The labels also warn of inflammation, meaning swelling and irritation, in the pancreas, as well as gallbladder problems and serious allergic reactions.
Bring those history questions to the person writing the prescription. Ask which symptoms need a prompt response and where to seek help.
A delivery question to resolve before use
The FDA says not to use injectable weight medicine that arrives warm or without enough cooling, because this may affect its quality.
Keep the package details and ask the pharmacist to resolve an unclear delivery or storage issue.